LA Private

Uncategorized

Stocks of the Hour: Noxopharm, Redstone Resources, Lake Resources

Noxopharm (ASX:NOX) announces that the US FDA has granted Orphan Drug Designation (ODD) status to Noxopharm’s CRO-67 preclinical drug candidate, for the treatment of pancreatic cancer. Noxopharm CEO Dr Gisela Mautner said, “our pancreatic cancer program is a high priority, and we are committed to progressing its development as quickly as possible. Further studies are

Stocks of the Hour: Noxopharm, Redstone Resources, Lake Resources Read More »

RBA’s Michelle Bullock steers steady course amidst economic uncertainty

Steady as Michelle Bullock took the reins as the new Governor at the Reserve Bank, judging by the statement from her first central bank monetary policy meeting on Tuesday. The RBA left the cash rate unchanged at 4.1% for the fourth consecutive month but also maintained the hawkish approach of her predecessor, warning that a

RBA’s Michelle Bullock steers steady course amidst economic uncertainty Read More »

Tesla still top dog, outpaces BYD in Q3 deliveries

Tesla held its position as the world’s leading EV manufacturer in the third quarter, narrowly surpassing Chinese auto giant BYD. During this period, Tesla reported shipping 435,059 vehicles globally, rebounding after facing its first delivery drop in over a year due to factory shutdowns. Despite this decline, the company remains confident in achieving its year-end

Tesla still top dog, outpaces BYD in Q3 deliveries Read More »